Industry Updates

Vical Within Days of Prototype H1N1 Vaccine | Xconomy08 May

Wow. Local biotech Vical shows how quickly their Vaxfectin process can scramble a new influenza vaccine for H1N1, following on success with H5N1 in clinical trials last year. Very impressive.

Leave a Reply

Company News

  • - 2013/03/04

    One of our team members is now working with Hospira on infuser product support. Contact us to find out more!

  • - 2010/10/24

    We're currently working with online elections provider Everyone Counts, Inc. Contact us to find out more!

Contact Us